Badri Rengarajan MD

Badri Rengarajan, MD is President of the Board of Directors of the International Pemphigus and Pemphigoid Foundation. He was previously Vice-President, Medical Affairs and Senior Principal Consultant at Evidera. His primary responsibilities included providing clinical input to modeling and analytics projects, leading consulting engagements, and building relationships with clients and clinical research leaders. He also provided clinical support to the IndiGO clinical decision support program. Badri’s areas of expertise include clinical trial design, drug and diagnostic development, health analytics, and strategy. Badri has over 15 years of healthcare industry experience including roles in product development strategy & new product planning, regulatory affairs, market research, and business development. Badri was previously a Director of Business Development and Market Research at Nodality (personalized/predictive medicine), biotechnology equities analyst at Lehman Brothers, Regulatory Team Leader at Genentech, and consultant with McKinsey and Company. Badri earned an A.B. in Biology and Public Policy from Harvard University and an M.D. from Yale University.